As of Mar 16
| +0.25 / +9.84%|
The 3 analysts offering 12-month price forecasts for BioTime Inc have a median target of 6.00, with a high estimate of 6.50 and a low estimate of 6.00. The median estimate represents a +115.05% increase from the last price of 2.79.
The current consensus among 3 polled investment analysts is to Buy stock in BioTime Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.